Skip to Content

Cardinal Health Inc - Stock Quote CAH

Rating as of

Morningstar's Cardinal Health Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Cardinal's Position in the Drug Distribution Oligopoly Warrants a Narrow Moat

Dylan Finley, CFA Equity Analyst

Business Strategy and Outlook

| Karen Andersen, CFA |

Cardinal Health is a leading domestic wholesaler of branded, generic, and specialty pharmaceutical products. With over $180 billion in annual U.S. drug distribution revenue, Cardinal Health supplies over one quarter of the overall market, slightly outpaced by AmerisourceBergen and McKesson in market share. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market. The highly consolidated pharmaceutical wholesale market reflects the substantial scale-based cost advantages held by the largest players.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics - CAH

Cardinal Health Inc's Company Profile

Business Description

Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Contact
7000 Cardinal Place
Dublin, OH, 43017
T +1 614 757-5000
Industry Medical Distribution
Most Recent Earnings Mar 31, 2022
Fiscal Year End Jun 30, 2022
Stock Type Slow Growth
Employees 47,300

Cardinal Health Inc's Related News